Technologies

Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care

  • by

BEDFORD, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, applauds the… Read More »Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care

111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 – Conference Call to Follow

  • by

​ SHANGHAI, Nov. 4, 2024 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream… Read More »111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 – Conference Call to Follow